Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions.

MLA

Wu, Zhichao, et al. “Molecular and Clinicopathologic Characteristics of Gliomas with EP300::BCOR Fusions.” Acta Neuropathologica, vol. 144, no. 6, Dec. 2022, pp. 1175–78. EBSCOhost, https://doi.org/10.1007/s00401-022-02508-2.

APA

Wu, Z., Rajan, S., Chung, H.-J., Raffeld, M., Panneer Selvam, P., Schweizer, L., Perry, A., Samuel, D., Giannini, C., Ragunathan, A., Frosch, M. P., Marshall, M. S., Boué, D. R., Donev, K., Neill, S. G., Fernandes, I., Resnick, A., Rood, B., Cummings, T. J., … Aldape, K. (2022). Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions. Acta Neuropathologica, 144(6), 1175–1178. https://doi.org/10.1007/s00401-022-02508-2

Chicago

Wu, Zhichao, Sharika Rajan, Hye-Jung Chung, Mark Raffeld, Pavalan Panneer Selvam, Leonille Schweizer, Arie Perry, et al. 2022. “Molecular and Clinicopathologic Characteristics of Gliomas with EP300::BCOR Fusions.” Acta Neuropathologica 144 (6): 1175–78. doi:10.1007/s00401-022-02508-2.